P

Inventor

TAN PAMELA

DE58 patents
⚠️ This page may combine multiple inventors who share the name “TAN PAMELA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALNYLAM PHARMACEUTICALS INC

25 patents
US7749978B2Jul 6, 2010

Compositions and methods for inhibiting expression of Huntingtin gene

ALNYLAM PHARMACEUTICALS INC113 citations99
US7718629B2May 18, 2010

Compositions and methods for inhibiting expression of Eg5 gene

ALNYLAM PHARMACEUTICALS INC241 citations99
US7605251B2Oct 20, 2009

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC160 citations99
US7320965B2Jan 22, 2008

Compositions and methods for inhibiting expression of Huntingtin gene

ALNYLAM PHARMACEUTICALS INC208 citations99
US7582745B2Sep 1, 2009

Compositions and methods for inhibiting expression of Nav1.8 gene

ALNYLAM PHARMACEUTICALS INC152 citations98
US9822365B2Nov 21, 2017

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC3 citations84
US9260718B2Feb 16, 2016

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC6 citations84
US8791250B2Jul 29, 2014

Compositions and methods for inhibiting expression of the HAMP gene

ALNYLAM PHARMACEUTICALS INC7 citations84
US7691824B2Apr 6, 2010

Compositions and methods for inhibiting expression of a gene from the JC virus

ALNYLAM PHARMACEUTICALS INC8 citations83
US10501742B2Dec 10, 2019

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC1 citations73
US7759320B2Jul 20, 2010

Compositions and methods for inhibiting expression of a gene from the Ebola

ALNYLAM PHARMACEUTICALS INC6 citations73
US9090895B2Jul 28, 2015

Compositions and methods for inhibiting expression of the HAMP gene

ALNYLAM PHARMACEUTICALS INC1 citations63
US8735369B2May 27, 2014

Compositions and methods for inhibiting expression of a gene from the Ebola virus

ALNYLAM PHARMACEUTICALS INC1 citations62
US7846908B2Dec 7, 2010

RNAi modulation of TGF-beta and therapeutic uses thereof

ALNYLAM PHARMACEUTICALS INC2 citations62
US7772200B2Aug 10, 2010

iRNA agents targeted to the Rho-A gene

ALNYLAM PHARMACEUTICALS INC2 citations62
US9102940B2Aug 11, 2015

RNAi modulation of SCAP and therapeutic uses thereof

ALNYLAM PHARMACEUTICALS INC1 citations60
US8383805B2Feb 26, 2013

RNAi modulation of SCAP and therapeutic uses thereof

ALNYLAM PHARMACEUTICALS INC1 citations60
US7919613B2Apr 5, 2011

RNAi modulation of SCAP and therapeutic uses thereof

ALNYLAM PHARMACEUTICALS INC1 citations60
US7812150B2Oct 12, 2010

RNAi modulation of Aha and therapeutic uses thereof

ALNYLAM PHARMACEUTICALS INC1 citations59
US9506067B2Nov 29, 2016

Compositions and methods for inhibiting expression of the HAMP gene

ALNYLAM PHARMACEUTICALS INC0 citations52
US9057069B2Jun 16, 2015

Compositions and methods for inhibiting expression of Eg5 gene

ALNYLAM PHARMACEUTICALS INC0 citations52
US7956177B2Jun 7, 2011

dsRNA compositions and methods for treating HPV infection

ALNYLAM PHARMACEUTICALS INC1 citations52
US7902168B2Mar 8, 2011

Compositions and methods for inhibiting expression of Nav1.8 gene

ALNYLAM PHARMACEUTICALS INC1 citations52
US9187516B2Nov 17, 2015

Compositions and methods for inhibiting expression of a gene from the Ebola virus

ALNYLAM PHARMACEUTICALS INC0 citations51
US9012624B2Apr 21, 2015

Compositions and methods for inhibiting expression of a gene from the JC virus

ALNYLAM PHARMACEUTICALS INC0 citations51

NOVARTIS AG

3 patents

TAN PAMELA

3 patents

NAKAYAMA TOMOKO

3 patents

VAN HEEKE GINO

3 patents

ARROWHEAD PHARMACEUTICALS INC

3 patents

SAH DINAH WEN-YEE

2 patents

MEDSTAR HEALTH INC

2 patents

BUMCROT DAVID

1 patent

SAH DINAH

1 patent

DSM IP ASSETS BV

1 patent

ARROWHEAD RES CORP

1 patent

UNIV TEXAS

1 patent

DE FOUGEROLLES ANTONIN

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.